Publications arising from the research of the ArrestAD project

– C. Vera, J.A. Alvarez-Orozco, A. Maïza, S. Chantepie, R.N. Chehin, M.O. Ouidja, D. Papy-Garcia. Heparan sulphates, amyloidosis and neurodegeneration. Revista de neurologia. 2017, 65(10), 457-468. (UPEC)

T.H. van Kuppevelt, A. Oosterhof, E.M.M. Versteeg, E. Podhumljak, E.M.A. van de Westerlo & W.F. Daamen. Sequencing of glycosaminoglycans with potential to interrogate sequence-specific interactions. Scientific reports. 2017, 7, 14785. doi:10.1038/s41598-017-15009-0. (RUMC)

– J. Wojsiat, K. Zoltowska, K. Laskowska-Kaszub, and U. Wojda. Oxidant/antioxidant imbalance in Alzheimer’s disease: therapeutic and diagnostic prospects. Oxidative Medicine and Cellular Longevity, 2018. doi:10.1155/2018/6435861.(NENCKI)

– Byrne, D., Ngamlert, P., Li, Y., Ramakrishnan, K., Eyers, C., Wells, C., Drewry, D., Zuercher, W., Berry, N. and Fernig, D.G., Eyers, P.A. New tools for evaluating protein tyrosine sulphation: Tyrosyl Protein Sulphotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors. Biochem. J. 2018, 475: 2435-2455. Open Access with accompanying editorial, originally published as a preprint). doi:10.1042/bcj20180266. (UoL)

– Byrne, D.P., Li, Y., Ramakrishnan, K., Barsukov, I., Yates, E.A. Eyers, C., Papy-Garcia, D., Chantepie, S., Pagadala, V., Liu, J., Wells, C., Drewry, D., Zuercher, W., Berry, N., Fernig, D.G. and Eyers P.A. New tools for carbohydrate sulphation analysis: Heparan Sulphate 2-O-sulphotranserase (HS2ST) is a target for small molecule protein kinase inhibitors. Biochem. J. 2018, 475: 2417-2433. Open Access with accompanying editorial, originally published as a preprint). doi:10.1042/BCJ20180265. (UoL)

– Baeta-Corral, R., Castro-Fuentes, R., Giménez-Llort, L. Sexual Dimorphism in the Behavioral Responses and the Immunoendocrine Status in d-Galactose-Induced AgingJ Gerontol A Biol Sci Med Sci. 2018, 73(9):1147-1157. doi: 10.1093/gerona/gly031. (UAB)

– Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U. microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Res Rev. 2018. pii: S1568-1637(18)30214-9. doi:10.1016/j.arr.2018.10.008  (NENCKI).

– Maïza A, Chantepie S, Vera C, Fifre A, Huynh MB, Stettler O, Ouidja MO, Papy-Garcia D. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration. FEBS Lett. 2018. Dec;592(23):3806-3818. doi: 10.1002/1873-3468.13082. Epub 2018 Jun 14. (UPEC)

– Alonso-López D, Campos-Laborie FJ, Gutiérrez MA, Lambourne L, Calderwood MA, Vidal M, De Las Rivas J. APID database: redefining protein-protein interaction experimental evidences and binary interactomes. Database. 2019 (accepted, in proofs). doi:10.1093/database/baz005 (FICUS).

– Huynh MB, Ouidja MO, Chantepie S, Carpentier G, Maïza A, Zhang G, Vilares J, Raisman-Vozari R, Papy-Garcia D. Glycosaminoglycans from Alzheimer’s disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau. PLoS One. 2019. 14(1):e0209573. doi: 10.1371/journal.pone.0209573. eCollection 2019. (UPEC).